Market Place
Sourcing Support
Alector’s AbbVie-Partnered Alzheimer’s Program Fails Ph 2
26 Nov 2024 //
BIOSPACE
Alector to Participate in Upcoming Healthcare Conferences
28 Feb 2024 //
PRESS RELEASE
Alector Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 2024 //
PRESS RELEASE
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
20 Feb 2024 //
PRESS RELEASE
Alector Announces Closing of Public Offering
19 Jan 2024 //
PRESS RELEASE
Alector Announces Pricing of Public Offering of Common Stock
17 Jan 2024 //
PRESS RELEASE
Alector Announces Proposed Public Offering of Common Stock
16 Jan 2024 //
PRESS RELEASE
Alector Reports Second Quarter 2023 Financial Results & Provides Business Update
03 Aug 2023 //
PRESS RELEASE
Here`s Why We`re Not Worried About Alector`s (NASDAQ:ALEC) Cash Burn Situation
27 Jun 2023 //
SIMPLY WALL
Alector cuts 11% of workforce as it doubles down on late-stage neuro programs
31 Mar 2023 //
BIOPHARMADIVE
Alector Announces Promotion of Clare Hunt to Chief People Officer
13 Oct 2022 //
GLOBENEWSWIRE
AbbVie dumps Alector`s Alzheimer`s immunotherapy after phase 1
09 Jul 2022 //
FIERCEBIOTECH
Alector Announces Appointment of Gary Romano, M.D., Ph.D., as CMO
29 Mar 2022 //
PRESS RELEASE
Alector Presents AL001 (latozinemab) Data from FTD-C9orf72 Cohort
15 Mar 2022 //
PRESS RELEASE
Alector to Present at Upcoming Healthcare Conferences
09 Mar 2022 //
PRESS RELEASE
Alector to Present New AL001 Data at AD/PD™ 2022
08 Mar 2022 //
PRESS RELEASE
Alector to Participate at the Cowen 42nd Annual Health Care Conference
01 Mar 2022 //
PRESS RELEASE
Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules
01 Mar 2022 //
PRESS RELEASE
With GSK, Alector to capitalize on big moment in Alzheimer`s
28 Jan 2022 //
FIERCEBIOTECH
Eric Ostertag reaching the end of the line as Poseida chief, and more
14 Jan 2022 //
ENDPTS
Alector to Present New Data from Multiple Pipeline Programs
03 Nov 2021 //
GLOBENEWSWIRE
Alector slides as two top executives plan to leave
08 Sep 2021 //
SEEKING ALPHA
Alector Reports Second Quarter 2021 Financial Results
03 Aug 2021 //
GLOBENEWSWIRE
Alector bolsters `immuno-neurology` approach with early data
30 Jul 2021 //
FIERCEBIOTECH
GSK and Alector ink neurodegenerative diseases partnership
05 Jul 2021 //
PHARMATIMES
GSK, under pressure to perform, pens $2.2B deal with Alector
03 Jul 2021 //
FIERCEBIOTECH
GSK, Alector to develop Parkinson`s, Alzheimer`s drugs in $2.2 bln deal
02 Jul 2021 //
REUTERS
Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL002
25 Jan 2021 //
GLOBENEWSWIRE
Alector Announces Departure of Chief Business Officer
20 Jan 2021 //
GLOBENEWSWIRE
Prevail and Alector both claim victory in arbitration over scientist-CEO
03 Nov 2020 //
ENDPTS
Alector Announces Promising Preliminary Data from AL001 Phase 1b and Ph 2
29 Jul 2020 //
GLOBENEWSWIRE
Innovent, Alector Enter Oncology Alliance
31 Mar 2020 //
CONTRACT PHARMA
Innovent Biologics Enters into a Collaboration with Alecto
26 Mar 2020 //
PRNEWSWIRE
Alector Announces FDA Fast Track Designation Granted to AL101
05 Feb 2020 //
GLOBENEWSWIRE
Shehnaaz Suliman dives back into Alzheimer`s at Alector
14 Dec 2019 //
ENDPTS
Alector, Prevail trade blows over founder`s work
17 Aug 2019 //
FIERCE BIOTECH
Scientist-CEO accused of improperly using confidential info from unicorn Alector
15 Aug 2019 //
ENDPTS
Polaris Partners — maps $400M for ninth fund
20 Jun 2019 //
ENDPTS
Alector, Lonza Partner for Neurodegeneration Therapy Manufacturing
10 May 2019 //
PHARMATECH
Alector, Lonza Partner for Mfg. of Neurodegeneration Therapies
06 May 2019 //
CONTRACT PHARMA
